Pathologic complete response to conversion therapy in hepatocellular carcinoma using patient-derived organoids: A case report

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

718

Figures (1-3)

Tables (1-1)

Sum=939

Publishing Process of This Article

Item

Count

Browse

Download

111

Sum=142

Nov 15, 2024 (publication date) through Feb 3, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastrointest Oncol. Nov 15, 2024; 16(11): 4506-4513
Published online Nov 15, 2024. doi: 10.4251/wjgo.v16.i11.4506

Full Size Figure Download Figure

Figure 3 The drug sensitivity results of the patient-derived organoid from hepatocellular carcinoma.

Citation: He YG, Wang Z, Li J, Xi W, Zhao CY, Huang XB, Zheng L. Pathologic complete response to conversion therapy in hepatocellular carcinoma using patient-derived organoids: A case report. World J Gastrointest Oncol 2024; 16(11): 4506-4513
URL: https://www.wjgnet.com/1948-5204/full/v16/i11/4506.htm
DOI: https://dx.doi.org/10.4251/wjgo.v16.i11.4506